Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 ...

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

For decades, the commercial distribution of protein powders and creatine monohydrate targeted a narrow demographic: strength athletes and bodybuilders. The broader consumer market frequently viewed ...

University Institute of Technology of Wood, University of Yaoundé I, Mbalmayo, Cameroon. 2 ISABEE of University of Ebolowa, ...

Exploring the engineering behind advanced printheads, durable ink systems, and efficient roll-to-roll production.

Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...

LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...

Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...

Prompt engineering tools help optimize AI-generated responses. Discover the best tools, compare features, and find the right ...

Radiation therapy remains a central modality in cancer treatment, but normal-tissue toxicity and long-term stochastic effects ...